<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>The Age of Personalized Medicine Blog</title>
	<atom:link href="http://ageofpersonalizedmedicine.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://ageofpersonalizedmedicine.wordpress.com</link>
	<description>Experts discuss the latest science and policy issues in personalized medicine</description>
	<lastBuildDate>Fri, 27 Jan 2012 19:26:47 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='ageofpersonalizedmedicine.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://0.gravatar.com/blavatar/8379485c170a5a6657e3325658973a1a?s=96&#038;d=http%3A%2F%2Fs2.wp.com%2Fi%2Fbuttonw-com.png</url>
		<title>The Age of Personalized Medicine Blog</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://ageofpersonalizedmedicine.wordpress.com/osd.xml" title="The Age of Personalized Medicine Blog" />
	<atom:link rel='hub' href='http://ageofpersonalizedmedicine.wordpress.com/?pushpress=hub'/>
		<item>
		<title>PCORI Research Priorities, Will They Support Personalized Medicine?</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2012/01/27/pcori-research-priorities-will-they-support-personalized-medicine/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2012/01/27/pcori-research-priorities-will-they-support-personalized-medicine/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 19:26:42 +0000</pubDate>
		<dc:creator>Amy Miller</dc:creator>
				<category><![CDATA[Biomarker research]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[NIH]]></category>
		<category><![CDATA[Patient Impact]]></category>
		<category><![CDATA[PCORI]]></category>
		<category><![CDATA[Policy Issues]]></category>
		<category><![CDATA[Translational research]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=851</guid>
		<description><![CDATA[The Board of Directors of the Patient-Centered Outcomes Research Institute (PCORI) met last week, outlined research priorities, and asked for public feedback. What I found most interesting, and a little disheartening, is that the priorities are drafted in vague language, making it difficult to determine how they may (or may not) support personalized medicine. I [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=851&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2012/01/27/pcori-research-priorities-will-they-support-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/9ab16970feb1f8917ec4e8da5068f902?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Amy Miller</media:title>
		</media:content>
	</item>
		<item>
		<title>Gene Patenting and Biological Methods in the Personalized Medicine Space</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/12/20/gene-patenting-biological-methods-in-personalized-medicine/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/12/20/gene-patenting-biological-methods-in-personalized-medicine/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 21:06:12 +0000</pubDate>
		<dc:creator>Jennifer Giordano-Coltart, Ph.D.</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=823</guid>
		<description><![CDATA[Richard S. Meyer contributed to this post. Personalized medicine, including the application of genomic and molecular data to better target the delivery of health care and determine a person’s predisposition to a particular disease or condition, continues to expand and become the clinical standard of care for many medical conditions or diseases.  For the past several [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=823&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/12/20/gene-patenting-biological-methods-in-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/01f01e7d93feffad5b85221109c94417?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jgcoltart</media:title>
		</media:content>
	</item>
		<item>
		<title>Adriana Jenkins and the Case for Personalized Medicine</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/12/12/adriana-jenkins-and-the-case-for-personalized-medicine/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/12/12/adriana-jenkins-and-the-case-for-personalized-medicine/#comments</comments>
		<pubDate>Mon, 12 Dec 2011 13:38:30 +0000</pubDate>
		<dc:creator>Kelly Lindenboom</dc:creator>
				<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Drug development]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Patient Impact]]></category>
		<category><![CDATA[Personalized Medicine Conference]]></category>
		<category><![CDATA[targeted therapies]]></category>
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=801</guid>
		<description><![CDATA[Adriana Jenkins passed away on February 9, 2011 after battling breast cancer. Known for her tenacious advocacy on behalf of targeted therapies, Kelly Lindenboom, honored her passionate work within the personalized medicine community at the Boston Reception hosted by the Personalized Medicine Coalition on November 8, 2011. Adriana Jenkins had an intoxicating personality and lived [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=801&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/12/12/adriana-jenkins-and-the-case-for-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/e96dcf7b0cbd55d2d90bd9ab8bc7b5d8?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">klindenboom</media:title>
		</media:content>
	</item>
		<item>
		<title>The Genomics and Personalized Medicine Act Needs a “Fresh Look”</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/10/11/the-genomics-and-personalized-medicine-act-needs-fresh-look/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/10/11/the-genomics-and-personalized-medicine-act-needs-fresh-look/#comments</comments>
		<pubDate>Tue, 11 Oct 2011 22:03:44 +0000</pubDate>
		<dc:creator>Amy Miller</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Genomics and Personalized Medicine Act]]></category>
		<category><![CDATA[Policy Issues]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=778</guid>
		<description><![CDATA[“Now is the time for a national effort to move personalized medicine forward,” said Representative Anna Eshoo at the Center for the Study of the Presidency and Congress and Health Affairs&#8217; Capitol Hill briefing held last week, on the same day that the Food and Drug Administration (FDA) released its plan Driving Biomedical Innovation:  Initiatives for [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=778&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/10/11/the-genomics-and-personalized-medicine-act-needs-fresh-look/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/9ab16970feb1f8917ec4e8da5068f902?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Amy Miller</media:title>
		</media:content>
	</item>
		<item>
		<title>Our Health Policies Can’t Ignore Where Science Is Leading Us</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/09/27/our-health-policies-cannot-ignore-where-science-is-leading-us/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/09/27/our-health-policies-cannot-ignore-where-science-is-leading-us/#comments</comments>
		<pubDate>Tue, 27 Sep 2011 15:24:38 +0000</pubDate>
		<dc:creator>Amy Miller</dc:creator>
				<category><![CDATA[Drug development]]></category>
		<category><![CDATA[Health care reform]]></category>
		<category><![CDATA[health cost containment]]></category>
		<category><![CDATA[Personalized health care]]></category>
		<category><![CDATA[targeted therapies]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=771</guid>
		<description><![CDATA[Do we want continued progress in personalized medicine, or don’t we? Based on events last week, the answer might be ‘both.’ I attended a press conference here in Washington that celebrated the achievements made by the health sector in our efforts to turn cancer from a sure death sentence into a chronic disease. Simultaneous to [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=771&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/09/27/our-health-policies-cannot-ignore-where-science-is-leading-us/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/9ab16970feb1f8917ec4e8da5068f902?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Amy Miller</media:title>
		</media:content>
	</item>
		<item>
		<title>Personalized Medicine: Celebrating Progress and Looking Ahead</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/09/26/personalized-medicine-celebrating-progress-and-looking-ahead/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/09/26/personalized-medicine-celebrating-progress-and-looking-ahead/#comments</comments>
		<pubDate>Mon, 26 Sep 2011 15:01:12 +0000</pubDate>
		<dc:creator>Edward Abrahams</dc:creator>
				<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Patient Impact]]></category>
		<category><![CDATA[Personalized health care]]></category>
		<category><![CDATA[Personalized Medicine Conference]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=752</guid>
		<description><![CDATA[The release of the American Association for Cancer Research (AACR) Cancer Progress Report last week, reminded me of the progress that has been made in cancer care since the passage of the National Cancer Act in 1971.  When President Nixon signed the law committing significant U.S. funds to cancer research, little was known about the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=752&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/09/26/personalized-medicine-celebrating-progress-and-looking-ahead/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/32aba727cc334f3ef1c5bd21bcee1e40?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Edward Abrahams</media:title>
		</media:content>
	</item>
		<item>
		<title>New Personalized Medicine Products Signal Progress for Patients</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/09/16/new-personalized-medicine-products-signal-progress-for-patients/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/09/16/new-personalized-medicine-products-signal-progress-for-patients/#comments</comments>
		<pubDate>Fri, 16 Sep 2011 18:54:56 +0000</pubDate>
		<dc:creator>Edward Abrahams</dc:creator>
				<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Drug development]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Patient Impact]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=736</guid>
		<description><![CDATA[The approvals of new treatments for two different types of cancer indicate that we are making significant progress in personalized medicine. Although the U.S. Food and Drug Administration (FDA) could further define a more transparent and predictable regulatory environment for personalized medicine products, the agency is clearly serious about personalized medicine. In August it cleared [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=736&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/09/16/new-personalized-medicine-products-signal-progress-for-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/32aba727cc334f3ef1c5bd21bcee1e40?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Edward Abrahams</media:title>
		</media:content>
	</item>
		<item>
		<title>Looking Forward, Looking Back</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/09/13/looking_forward_looking_back/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/09/13/looking_forward_looking_back/#comments</comments>
		<pubDate>Tue, 13 Sep 2011 14:10:13 +0000</pubDate>
		<dc:creator>Lawrence J. Lesko, Ph.D., F.C.P.</dc:creator>
				<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Drug development]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Genomics and Personalized Medicine Act]]></category>
		<category><![CDATA[Innovation]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=725</guid>
		<description><![CDATA[At the Food and Drug Administration (FDA), I had a wonderful opportunity to spend nearly 20 years working in various capacities: in drug development science, regulatory oversight, and clinical pharmacology. Earlier this summer, I had the privilege to meet with the Personalized Medicine Coalition’s public policy committee to discuss the state of personalized medicine just [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=725&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/09/13/looking_forward_looking_back/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/c72e826631b4996fd5c501e0cc8488e7?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">llesko</media:title>
		</media:content>
	</item>
		<item>
		<title>Legislative Specifications Would Create a Path Forward for Personalized Medicine</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/08/23/legislative-specifications-would-create-a-path-forward-for-personalized-medicine/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/08/23/legislative-specifications-would-create-a-path-forward-for-personalized-medicine/#comments</comments>
		<pubDate>Tue, 23 Aug 2011 19:21:40 +0000</pubDate>
		<dc:creator>Amy Miller</dc:creator>
				<category><![CDATA[Genomics and Personalized Medicine Act]]></category>
		<category><![CDATA[Policy Issues]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=705</guid>
		<description><![CDATA[The Personalized Medicine Coalition has a long history of working with Congress on the Genomics and Personalized Medicine Act (GPMA); a bipartisan bill first introduced by Senators Obama and Burr in 2007.  The original bill was designed to take full advantage of our federal investment in the Human Genome Project by putting policies in place [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=705&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/08/23/legislative-specifications-would-create-a-path-forward-for-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/9ab16970feb1f8917ec4e8da5068f902?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Amy Miller</media:title>
		</media:content>
	</item>
		<item>
		<title>FDA Issues Draft Guidance for Rx/Dx Co-Development – What’s Next?</title>
		<link>http://ageofpersonalizedmedicine.wordpress.com/2011/07/21/fda_issues_draft_guidancerxdx_whats_next/</link>
		<comments>http://ageofpersonalizedmedicine.wordpress.com/2011/07/21/fda_issues_draft_guidancerxdx_whats_next/#comments</comments>
		<pubDate>Thu, 21 Jul 2011 21:46:31 +0000</pubDate>
		<dc:creator>Amy Miller</dc:creator>
				<category><![CDATA[FDA]]></category>
		<category><![CDATA[Genomics and Personalized Medicine Act]]></category>

		<guid isPermaLink="false">http://ageofpersonalizedmedicine.wordpress.com/?p=700</guid>
		<description><![CDATA[FDA released long-awaited draft guidance on its regulation of co-developed drug diagnostic combination products.  PMC asked FDA to issue a draft guidance on this topic since innovators had many questions about how regulation of these two products together would work.  I can describe it in one word: short. It outlines a collaborative process through FDA [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=ageofpersonalizedmedicine.wordpress.com&amp;blog=9814405&amp;post=700&amp;subd=ageofpersonalizedmedicine&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://ageofpersonalizedmedicine.wordpress.com/2011/07/21/fda_issues_draft_guidancerxdx_whats_next/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/9ab16970feb1f8917ec4e8da5068f902?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Amy Miller</media:title>
		</media:content>
	</item>
	</channel>
</rss>
